Arsenic exposure in utero exacerbates skin cancer response in adulthood with contemporaneous distortion of tumor stem cell dynamics.
D000818:Animals; D018952:Antigens, CD34 / Q000032:analysis / Q000235:genetics; D001151:Arsenic / Q000633:toxicity*; D002294:Carcinoma, Squamous Cell / Q000139:chemically induced / Q000235:genetics; D018797:Cell Cycle Proteins; D005260:Female; D005333:Fetus / Q000187:drug effects*; D011905:Genes, ras; D051379:Mice; D014411:Neoplastic Stem Cells / Q000187:drug effects*; D009479:Neuropeptides / Q000032:analysis / Q000235:genetics; D011247:Pregnancy; D011506:Proteins; D012878:Skin Neoplasms / Q000139:chemically induced* / Q000235:genetics; D013755:Tetradecanoylphorbol Acetate / Q000633:toxicity; D020744:rac GTP-Binding Proteins / Q000032:analysis / Q000235:genetics; D020830:rac1 GTP-Binding Protein
D018952:Antigens, CD34; D018797:Cell Cycle Proteins; D009479:Neuropeptides; D011506:Proteins; C484602:Rac1 protein, mouse; C108199:Shfdg1 protein, mouse; D020744:rac GTP-Binding Proteins; D020830:rac1 GTP-Binding Protein; D001151:Arsenic; D013755:Tetradecanoylphorbol Acetate